Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis
- 31 July 1996
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 25 (1), 49-57
- https://doi.org/10.1016/s0168-8278(96)80327-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisJournal of Hepatology, 1994
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisThe New England Journal of Medicine, 1994
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosisJournal of Hepatology, 1994
- A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosisJournal of Gastroenterology and Hepatology, 1994
- Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid aloneJournal of Hepatology, 1993
- Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: Preliminary analysis of a double-blind multicenter trialJournal of Hepatology, 1993
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisThe New England Journal of Medicine, 1991
- A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosisGastroenterologia Japonica, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989